About TARGAN
TARGAN is a company based in Morrisville (United States) founded in 2015 by Ramin Karimpour. TARGAN has raised $65.9 million across 6 funding rounds from investors including Merck Animal Health, Mountain Group Partners and NovaQuest Capital Management. The company has 29 employees as of December 31, 2021. TARGAN operates in a competitive market with competitors including Merck Animal Health, Intervacc, VitamFero, Pacific GeneTech and Harrisvaccines, among others.
- Headquarter Morrisville, United States
- Employees 29 as on 31 Dec, 2021
- Founders Ramin Karimpour
-
Sectors
Agriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Targan Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$65.9 M (USD)
in 6 rounds
-
Latest Funding Round
$35 M (USD), Series C
May 25, 2022
-
Investors
Merck Animal Health
& 4 more
-
Employee Count
29
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of TARGAN
Unlock access to complete
Unlock access to complete
Funding Insights of TARGAN
TARGAN has successfully raised a total of $65.9M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TARGAN
TARGAN has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck Animal Health, Mountain Group Partners and NovaQuest Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is directed toward life sciences and technology sectors.
|
Locked | Locked | Locked | |
|
PE firm focused on life science and healthcare companies
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are provided by Oval Park Capital.
|
Locked | Locked | Locked |
Investor details for TARGAN
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TARGAN
Investment portfolio details for TARGAN
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TARGAN
Detailed financials for TARGAN
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Targan Comparisons
Peer comparison for TARGAN
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TARGAN
TARGAN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, Intervacc, VitamFero, Pacific GeneTech and Harrisvaccines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine technology is developed and supplied for livestock animals.
|
|
| Locked | Locked | Locked |
Recombinant vaccines for cattle, equine, and other livestock are developed.
|
|
| Locked | Locked | Locked |
Offers patented immunostimulating vaccines for livestock.
|
|
| Locked | Locked | Locked |
Developer of vaccines and gene delivery platform
|
|
| Locked | Locked | Locked |
Developer of vaccine technology for the treatment of infectious diseases
|
Detailed competitors of TARGAN
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Targan
Complete news archive for TARGAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TARGAN
TARGAN was founded in 2015 and raised its 1st funding round 3 years after it was founded.
TARGAN is headquartered in Morrisville, United States.
Ramin Karimpour is the current CEO of TARGAN. They have also founded this company.
TARGAN is a funded company, having raised a total of $65.9M across 6 funding rounds to date.
As of Dec 31, 2021, the latest employee count at TARGAN is 29.
Founded in 2015 and based in Morrisville, United States, automated targeted vaccine delivery systems are developed by the company for livestock and aquaculture sectors. Technologies including high-speed imaging, microfluidics, artificial intelligence, and humane animal handling are integrated to provide vaccination solutions that reduce infection-related losses. Solutions are offered for aquaculture, pigs, and poultry operations.
TARGAN's top competitors include Merck Animal Health, Intervacc and Pacific GeneTech.
TARGAN has 5 investors. Key investors include Merck Animal Health, Mountain Group Partners, NovaQuest Capital Management, Oval Park Capital, and National Science Foundation.